胎儿生长受限中的胎儿胰腺:代谢与遗传风险的产前窗口
回顾性队列纳入69例胎儿生长受限(FGR)胎儿,超声测量胰腺周长并对照标准参考值。多数(75%)胎儿胰腺周长≤第50百分位,36.2%低于第10百分位,27.5%低于第5百分位;胰腺大小与估计胎儿体重(r=0.53)及腹围(r=0.54)中度相关,与孕龄无关。作者认为FGR胎儿胰腺偏小,胰腺可作新型影像标志物,并需进一步研究长期代谢编程。
要点
- FGR胎儿中75%胰腺周长≤第50百分位,36.2%低于第10百分位。
- 胰腺周长与估计胎儿体重(r=0.53)和腹围(r=0.54)中度相关,与孕龄无关。
- 作者认为胰腺可作为FGR的新型影像标志物,并需进一步研究长期代谢编程。
核心结论
- FGR胎儿表现为胰腺尺寸减小,作者认为胰腺可作为新型影像标志物,并需进一步研究长期代谢编程。
研究设计与样本
- 回顾性队列研究,纳入在一家三级中心接受产前超声、诊断为FGR的胎儿69例。
- 测量胰腺周长并与已建立的标准参考值比较,分析胰腺大小与估计胎儿体重、腹围、多普勒检查结果、孕龄、合并妊娠期糖尿病及解剖或遗传异常的关系。
- 超声检查及胰腺测量时的平均孕龄为31.5±3.5周。
主要发现
- 多数队列(75%)的胰腺周长处于或小于标准参考值第50百分位。
- 36.2%的病例胰腺周长低于第10百分位,27.5%低于第5百分位。
- 胰腺大小与估计胎儿体重中度相关(r=0.53),与腹围中度相关(r=0.54),与孕龄无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Animal models have demonstrated impaired pancreatic islet development in fetal growth restriction (FGR) cases, which can become apparent at or before birth and persist into adulthood, resulting in glucose intolerance. This study assessed the relationship between fetal pancreatic biometry and FGR. METHODS: A retrospective cohort study included fetuses diagnosed with FGR who underwent prenatal ultrasound at a tertiary center. Pancreatic circumference was measured and compared with established normative reference values. Associations between pancreatic size and estimated fetal weight (EFW), abdominal circumference (AC), Doppler findings, gestational age (GA), concurrent gestational diabetes mellitus (GDM), and the presence of anatomical or genetic abnormalities were analyzed. RESULTS: The study group comprised 69 cases. The mean GA at the ultrasound examination and pancreatic measurement was 31.5 ± 3.5 weeks. Pancreatic circumference was at or smaller than the 50th percentile of normative references in the majority of the cohort (75%), with 36.2% of cases falling below the 10th percentile and 27.5% below the 5th percentile. Pancreas size correlated moderately with EFW (r = 0.53) and AC (r = 0.54) but not with GA. CONCLUSION: Fetuses with FGR exhibited reduced pancreatic size. These findings highlight the pancreas as a novel imaging marker and warrant further investigation into long-term metabolic programming.
引用
- Miremberg H, Bobrow C, Feldman N, et al. Fetal Pancreas in Growth Restriction: A Prenatal Window Into Metabolic and Genetic Risk. Prenat Diagn. 2025. PMID: 41082213. doi:10.1002/pd.70004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。